Alzheimer's Diagnostic Modalities

Facilitators: Jason Karlawish, MD & Kyra O’Brien, MD

This interactive workshop will focus on answering your questions about imaging and blood-based diagnostic biomarkers for Alzheimer's and other common causes of dementia. The audience will be led through discussions of clinical cases highlighting the use and interpretation of imaging (MRI and PET), spinal fluid, and blood biomarkers in the evaluation of Alzheimer's disease (AD) and related causes of dementia. The audience will review imaging and blood biomarker findings and vote on their interpretation. Learning Objectives: (1) review biomarker studies and discuss their usage in the diagnosis of AD, vascular cognitive impairment, Lewy body disease, and Limbic-Predominant Age-Related TDP-43 Encephalopathy (LATE); and (2) assess the utility of blood-based biomarkers in evaluating for early-stage AD.